Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial
针对复发或难治性 B 细胞非霍奇金淋巴瘤患者的 CD19/20 的双特异性 CAR-T 细胞：一项 I/II 期临床试验
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/s41408-024-01105-8
Lixin Wang #, Chuling Fang #, Qingzheng Kang, Wenfa Huang, Ziren Chen, Weiqiang Zhao, Lei Wang, Yiran Wang, Kun Tan, Xiao Guo, Yuanyuan Xu, Shuhong Wang, Lijun Wang, Jingqiao Qiao, Zhixiong Tang, Chuan Yu, Yang Xu, Yisheng Li, Li Yu
